HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

B D Cheson Selected Research

galiximab

11/2018Phase II trial of galiximab (anti-CD80 monoclonal antibody) plus rituximab (CALGB 50402): Follicular Lymphoma International Prognostic Index (FLIPI) score is predictive of upfront immunotherapy responsiveness.
9/2012Phase II trial of galiximab (anti-CD80 monoclonal antibody) plus rituximab (CALGB 50402): Follicular Lymphoma International Prognostic Index (FLIPI) score is predictive of upfront immunotherapy responsiveness.
7/2007A phase I/II study of galiximab (an anti-CD80 monoclonal antibody) in combination with rituximab for relapsed or refractory, follicular lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


B D Cheson Research Topics

Disease

8Lymphoma (Lymphomas)
07/2015 - 04/2000
5Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
11/2018 - 07/2007
3B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2017 - 12/2000
3Neoplasms (Cancer)
07/2015 - 05/2001
2Non-Hodgkin Lymphoma (Lymphosarcoma)
11/2017 - 04/2000
2Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
07/2015 - 05/2008
2Vomiting
10/2014 - 05/2008
2Thrombocytopenia (Thrombopenia)
10/2014 - 05/2008
2Diarrhea
10/2014 - 05/2008
2Neutropenia
10/2014 - 12/2000
2Fatigue
10/2014 - 05/2008
2Nausea
10/2014 - 05/2008
2Hodgkin Disease (Hodgkin's Disease)
11/2010 - 06/2007
2Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2001 - 10/2000
1Peripheral Nervous System Diseases (PNS Diseases)
10/2014
1Leukemia
11/2010
1Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
05/2008
1Anemia
05/2008
1Asthenia
05/2008
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2001
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2001
1Infections
12/2000
1Cardiotoxicity
11/2000
1Acute Promyelocytic Leukemia
10/2000

Drug/Important Bio-Agent (IBA)

5Rituximab (Mabthera)FDA Link
11/2018 - 04/2000
4Pharmaceutical PreparationsIBA
10/2014 - 12/2000
3galiximabIBA
11/2018 - 07/2007
3Monoclonal AntibodiesIBA
11/2018 - 07/2007
2AntibodiesIBA
07/2015 - 11/2010
2GemcitabineFDA Link
11/2010 - 06/2007
2liposomal doxorubicin (Doxil)FDA Link
11/2010 - 06/2007
2Vinorelbine (Navelbine)FDA LinkGeneric
11/2010 - 06/2007
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
10/2009 - 11/2000
2Proteasome Endopeptidase Complex (Proteasome)IBA
05/2001 - 01/2001
1Lenalidomide (CC 5013)FDA Link
11/2017
1ibrutinibIBA
01/2017
1idelalisibIBA
01/2017
1venetoclaxIBA
01/2017
1AntigensIBA
07/2015
1Immunoconjugates (Immunoconjugate)IBA
07/2015
1Proteasome InhibitorsIBA
10/2014
1ixazomibIBA
10/2014
1Interferon-alpha2bIBA
10/2009
1Interferon alpha-2 (Roferon-A)FDA Link
10/2009
1VorinostatFDA Link
05/2008
1Biological ProductsIBA
07/2007
1Immunoglobulins (Immunoglobulin)IBA
12/2001
1Histone Deacetylases (Histone Deacetylase)IBA
05/2001
1Cyclin D1IBA
01/2001
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2001
1alvocidib (flavopiridol)IBA
01/2001
1Proteins (Proteins, Gene)FDA Link
01/2001
1Antisense OligonucleotidesIBA
01/2001
1Chlorambucil (Leukeran)FDA Link
12/2000
1fludarabineIBA
12/2000
1Doxorubicin (Adriamycin)FDA LinkGeneric
11/2000
1Vincristine (Oncovin)FDA LinkGeneric
11/2000
1Prednisone (Sone)FDA LinkGeneric
11/2000
1Etoposide (VP 16)FDA LinkGeneric
11/2000
1Arsenic Trioxide (Trisenox)FDA Link
10/2000

Therapy/Procedure

3Therapeutics
10/2014 - 12/2000
3Drug Therapy (Chemotherapy)
10/2009 - 10/2000
2Immunotherapy
11/2018 - 09/2012
1Salvage Therapy
06/2007